JP Stock MarketDetailed Quotes

6810 Maxell

Watchlist
  • 1928
  • +30+1.58%
20min DelayTrading Feb 18 09:34 JST
90.53BMarket Cap11.71P/E (Static)

Maxell Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Maxell Q3 2025 Earnings Date

Currency：JPYJan 31, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
32.35B
32.47B
+115.00M
Beat Est.
+2.10%
+2.46%
+0.36%
EPS
35.47
56.48
+21.01
Beat Est.
+116.54%
+244.81%
+59.23%
Analyst Rating
Buy

Feb 17, 2025

Maxell Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/Q1-- / 31.600B--
--2025/Q4-- / 30.963B--
Jan 31, 20252025/Q332.465B / 32.350B--
Oct 31, 20242025/Q231.737B / 32.333B--
Jul 31, 20242025/Q131.385B / 30.633B--
DatePeriodRevenue/EstimateEarnings Call
--2026/Q1-- / 31.600B--
--2025/Q4-- / 30.963B--
Jan 31, 20252025/Q332.465B / 32.350B--
Oct 31, 20242025/Q231.737B / 32.333B--
Jul 31, 20242025/Q131.385B / 30.633B--

Unlock Free Earnings Estimates

Maxell Earnings Reports

  • Maxell: Summary of Financial Results for the 3rd Quarter Ending March 31, 2025 [Japanese GAAP] (Consolidated)

    Jan 31 01:30 ET

  • Maxell: Confirmatory letter.

    Nov 11, 2024 02:03 ET

  • Maxell: Half Year Report - Term 79 (2024/04/01 - 2025/03/31)

    Nov 11, 2024 02:02 ET

  • Maxell: Notice regarding dividends from surplus funds (interim dividends)

    Oct 31, 2024 02:00 ET

    • Read more

    Top JP Stock Gainers
    Symbol Price % Chg
    D. Western Therapeutics Institute
    4576
    173 +21.83%
    Itamiarts
    168A
    1392 +17.87%
    Rentracks
    6045
    1284 +17.80%
    Washington Hotel
    4691
    1167 +13.19%
    Next Generation Technology Group
    319A
    4550 +12.62%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Feb 17, 2025

    Buy

    • Strong Buy

      28.57%

    • Buy

      28.57%

    • Hold

      28.57%

    • Underperform

      14.29%

    • Sell

      0.00%

    Price Target

    No Data